Tag: Drug

Arthritis drug improves survival odds for COVID-19 patients treated with remdesivir by 35%, NIH study finds An NIH trial tested a combination of Eli Lilly’s arthritis drug, barcitinib, and the antiviral  remdesivir to treat COVID-19  Overall, those who got both drugs were 35% more likely to survive than those given remdesivir alone  People on supplemental

Researchers at ETH Zurich have developed a method for concentrating and releasing drugs in the brain with pinpoint accuracy. This could make it possible in the future to deliver psychiatric and cancer drugs and other medications only to those regions of the brain where this is medically desirable. Today, this is practically impossible—drugs traveling through

A Rutgers-led team has created a smart drug delivery system that reduces inflammation in damaged nervous tissues and may help treat spinal cord injuries and other neurological disorders. The system, which uses extremely thin biomaterials implanted in the body, also protects nerve fibers (axons) that connect nerve cells in injured neural tissues, according to a

Following a large-scale clinical trial, researchers have found that lanthanum carbonate does not reduce the risk of cardiovascular disease developing in patients with chronic kidney disease. The drug is routinely prescribed to patients with chronic kidney disease to help reduce the risk of both bone disease and cardiovascular disease, with cardiovascular disease the most common

Restricting access to high-risk medications via a real-time prescription monitoring program such as Victoria’s SafeScript may help reduce inappropriate use, but integrated mental health and drug treatment services may be necessary to offset the risk of increased mortality, according to the authors of a letter published online by the Medical Journal of Australia. Researchers from

Study shows potential of heartburn drug for COVID-19 According to an observational study, which was conducted at Irving, Medical Center of Columbia University (USA), could help a common drug for heartburn by the Coronavirus SARS-CoV-2-induced disease COVID-19. In a new study has shown that COVID-19-patients and in -patients in the Famotidine, a common drug for

(HealthDay)—Despite numerous studies suggesting that certain drugs touted by President Donald Trump as “game changers” against coronavirus are actually useless and even harmful, Trump on Monday claimed he has been taking one of them for more than a week. Trump said he has been taking the drug hydroxychloroquine for about a week and a half

Researchers at University of California San Diego School of Medicine have launched a clinical trial to investigate whether a drug approved for treating high blood pressure, heart failure and diabetic kidney disease might also reduce the severity of COVID-19 infections, lowering rates for intensive care unit admissions, the use of mechanical ventilators and all-cause mortality.

An international study will test whether a common anti-inflammatory drug can ward off serious complications from COVID-19 and possibly prevent patients from ending up in the hospital. The study, which would involve 6,000 participants in the U.S., Canada and Europe, is designed to be “contactless” — participants will receive the drug, called colchicine, by mail,

The Russian government has authorised the use of an anti-malarial drug to treat coronavirus patients despite international concerns over its safety and effectiveness. The government published an order late Thursday allowing the use of hydroxychloroquine on patients after China donated more than 68,000 packs of the tablets to Russia. The order was published after President

Trump claims an anti-malaria drug is APPROVED to treat coronavirus – but is corrected by the FDA head who says it is still ‘experimental’ and will be studied in some American patients President Trump said in a Thursday press conference that the anti-malaria drug hydroxychloroquine had been FDA-approved to treat coronavirus patients  FDA Commissioner Stephen

Four per cent of MDMA-related deaths in Australia since 2000 occurred at music festivals, according to a new report from the National Drug and Alcohol Research Centre (NDARC). The study, published in the International Journal of Drug policy this month, identifies 392 deaths linked to the drug between 2000 and 2018. Most deaths occurred in

A clinical trial investigating the repurposed cancer drug nilotinib in people with Parkinson’s disease finds that it is reasonably safe and well tolerated. Researchers also report finding an increase in dopamine, the chemical lost as a result of neuronal destruction, and a decrease in neurotoxic proteins in the brain among study participants. Finally, they say

U.S. health regulators approved a second drug for a debilitating form of muscular dystrophy, a surprise decision after the medication was rejected for safety concerns just four months ago. The ruling marks the second time the Food and Drug Administration has granted preliminary approval for the disease based on early results and is likely to

A drug commonly used to treat Type II diabetes abolishes the characteristic signs of nicotine withdrawal in rats and mice, according to new research published in JNeurosci. The finding may offer an important new strategy in the battle to quit smoking. Smokers trying to quit face potent side effects from nicotine withdrawal, including cravings, increased

Hostile and competitive people are more likely to give in to drug consumption, according to a study published by a research group at the University of Cordoba (Spain). When a person faces a decision regarding these kinds of substances, multiple factors come into play, such as social environment, family history and past experiences. Now, this

An experimental targeted drug could treat a rare type of cancer usually affecting the limbs, a clinical trial led by The Institute of Cancer Research, London, has shown. The important trial could lead to a much-needed new treatment for patients with alveolar soft part sarcoma (ASPS), which tends to affect younger adults and does not

A potential drug to treat heart attacks and to prevent heart failure—for which no cure currently exists—may result from pioneering research by a University of Guelph professor. Prof. Tami Martino, Department of Biomedical Sciences, and Ph.D. student Cristine Reitz have discovered what they believe is a novel drug target controlling the body’s repair responses after

A drug used to treat chronic myeloid leukemia appears to be more effective at stopping a type of medulloblastoma in mouse models than existing treatments for the deadly pediatric brain tumor, reports a multi-institutional team led by researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego. In the study,

Breakthrough research has revealed a new drug that may prevent the spread of malaria, and also treat people suffering with the deadly parasitic disease. The findings, which were delivered by an international team of scientists led by the University of Glasgow and published today in Science, offer fresh hope in the global fight against malaria.